PIRARUBICIN for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 38 adverse event reports in the FDA FAERS database where PIRARUBICIN was used for Neoplasm.
Most Reported Side Effects for PIRARUBICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 408 | 30.3% | 5 | 260 |
| White blood cell count decreased | 207 | 15.4% | 9 | 114 |
| Neutrophil count decreased | 145 | 10.8% | 3 | 90 |
| Bone marrow failure | 127 | 9.4% | 14 | 55 |
| Nausea | 111 | 8.2% | 2 | 68 |
| Vomiting | 104 | 7.7% | 2 | 70 |
| Gastrointestinal disorder | 58 | 4.3% | 1 | 39 |
| Leukopenia | 55 | 4.1% | 0 | 21 |
| Pyrexia | 55 | 4.1% | 4 | 36 |
| Neutropenia | 54 | 4.0% | 13 | 18 |
| Febrile neutropenia | 53 | 3.9% | 13 | 16 |
| Decreased appetite | 50 | 3.7% | 7 | 20 |
| Platelet count decreased | 43 | 3.2% | 6 | 21 |
| Anaemia | 42 | 3.1% | 6 | 13 |
| Hepatic function abnormal | 41 | 3.0% | 3 | 11 |
Other Indications for PIRARUBICIN
Breast cancer female (271)
Diffuse large b-cell lymphoma (175)
Chemotherapy (135)
Breast cancer (82)
Lymphoma (68)
Invasive ductal breast carcinoma (56)
Acute lymphocytic leukaemia (51)
Non-hodgkin's lymphoma (40)
B-cell lymphoma (36)
Neoplasm malignant (34)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)